U.S. Representative Jake Auchincloss, who represents Massachusetts’ 4th district in Congress, posted a series of statements on social media from July 16 to July 17, 2025, addressing issues ranging from social media regulation and artificial intelligence to legislative disagreements over digital currency and FDA authority.
On July 16, Auchincloss commented on the impact of social media corporations on younger generations, writing: “Gloves off with the social media corporations. They attention-fracked Gen Z. Now with AI, Gen Alpha will be treated even worse unless Congress acts.”
Early the next morning, he discussed legislative strategy concerning central bank digital currencies (CBDC) and bipartisan cooperation. He stated: “If the majority whip had gone with my bipartisan Power of the Mint Act, introduced last term with French Hill, instead of his partisan anti-CBDC bill, then it would not be a poison pill to combine CLARITY with CBDC legislation. I’ve reintroduced Power of the Mint today— it makes”
Later that day, Auchincloss addressed the role of the Food & Drug Administration Commissioner in drug approval processes. He wrote: “The Commissioner of the Food & Drug Administration has no authority to offer special approval pathways based on his policy preferences. Congress mandates that clinical data proving safety & efficacy should be evaluated by scientists who grant approval. The Commissioner’s National”
Jake Auchincloss has represented Massachusetts’s 4th District in Congress since 2021 after succeeding Joe Kennedy III. Prior to his current role, he served in the Massachusetts House of Representatives and is a resident of Newton, Massachusetts. Born in Newton in 1988, Auchincloss holds degrees from Harvard University and the Massachusetts Institute of Technology.
